Boom to start Tour despite low cortisol levels


  • Cycling
  • Saturday, 04 Jul 2015

Astana rider Vincenzo Nibali of Italy (R) cycles with team mate Dutch rider Lars Boom during a training session in Utrecht, Netherlands, July 3, 2015. REUTERS/Eric Gaillard

UTRECHT, Netherlands (Reuters) - Dutchman Lars Boom will start Saturday's first stage of the Tour de France despite showing low levels of cortisol in a test on the eve of the race, his Astana team manager said.

Low levels of the hormone can be explained by the use of corticoids, anti-inflammatory drugs that are allowed out of competition but forbidden while racing unless a rider is granted a Therapeutic Use Exemption (TUE).

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Cycling

Cycling-Sanchez wins Giro stage six, Pogacar retains lead
Pedal to the medal
Cycling-Cranking it up for Paris, new bike set to keep British on a roll
Cycling-Benjamin Thomas wins Giro stage five after breakaway holds off peloton
Shah Firdaus ready to step up and challenge world’s top riders in Paris
Cycling-Milan outsprints Groves to win Giro stage four, Pogacar leads
Cycling-Vingegaard back on bike outside, hopeful for Tour defence
Cycling-Merlier sprints to Giro stage three win, Pogacar still in pink
Motorcycling-New MotoGP rules applicable from 2027 seek to make races safer
Young riders’ fine outing in Australia a good sign for the future

Others Also Read